Crossmark

Asthma control and exacerbations in patients with severe asthma treated with omalizumab in Portugal

Crossref DOI link: https://doi.org/10.1016/j.rppnen.2015.03.002

Published Print: 2015-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sousa, A.S.

Pereira, A.M.

Fonseca, J.A.

Azevedo, L.F.

Abreu, C.

Arrobas, A.

Calvo, T.

Silvestre, M.J.

Cunha, L.

Falcão, H.

Drummond, M.

Geraldes, L.

Loureiro, C.
Funding

Funding for this research was provided by:

Novartis
License Information

Text and Data Mining valid from 2015-11-01
More Information

This article is maintained by: Elsevier

Article Title: Asthma control and exacerbations in patients with severe asthma treated with omalizumab in Portugal

Journal Title: Revista Portuguesa de Pneumologia (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rppnen.2015.03.002

Content Type: article

Copyright: Copyright © 2014 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L. All rights reserved.